Industry Research Report

Thursday, 22 August 2019

Ostomy Care Market Size to Reach $4.1 Billion By 2024 | CAGR: 4.4%

New York, NY 22 Aug 2019 According to a new study published by Polaris Market Research, the global ostomy care market is anticipated to reach USD 4.1 billion by 2024. Ostomy, also known as stoma is a surgical procedure that involves the removal of diseased portions of the urinary or gastrointestinal system and formation of an artificial opening in the stomach or abdomen to allow the elimination of body wastes. Colostomy, Ileostomy, and Urostomy are the three types of ostomy. In the colostomy, the opening is made from the large intestine to the abdominal wall so the feces can bypass through the anal canal. In Urostomy, the urine passes straight into a stoma bag and thus bypasses through urethra. In Ileostomy, the damaged part is removed from the ileum and diverted to an artificial opening in the abdominal wall.

The global ostomy care market is driven by the rising geriatric population and increased number of ostomy surgeries in bladder cancer, bowel cancer, and inflammatory bowel diseases. Moreover, rising number of patient awareness programs on the use of ostomy products, and new product innovation are some of the key factors responsible for the growth of the market over the forecast period. However, difficult reimbursement climate and increased cost of surgical care are factors expected to stifle the growth of the global ostomy care market through the foreseeable future.

Get Sample Copy of this Report @ https://www.polarismarketresearch.com/industry-analysis/ostomy-care-market/request-for-sample

The overall market is segmented on the basis of product type, end user, and region. Based on the product, the global ostomy care market is further categorized into bags and accessories. The bags segment is further sub segmented into surgery type, usability, shape and system type. The surgery type is further broken down into colostomy, ileostomy, and urostomy. Among the surgery types, colostomy surgery is expected to exhibit strong growth followed by Ileostomy and urostomy. By usability, the bags are segmented into close end and drainable bags. On the basis of system type, the market is segmented into one-piece systems, and two-piece systems.

Accessories remain a very important part of the product offering and are a rapidly growing segment within ostomy care market. The accessories segment of global ostomy care market is further segmented into creams, deodorants, powders & pastes, cleansers, belt, tapes, and others.

On the basis of end user, the global ostomy care market is further segmented into hospitals, specialty clinics, home care settings, and ambulatory surgical centers. In 2017, the home care settings segment is estimated to dominate the global ostomy care market.

Get Exclusive Discount Offer @ https://www.polarismarketresearch.com/industry-analysis/ostomy-care-market/request-for-discount-pricing

By geography, the global ostomy care market is segmented into five major regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Europe is estimated to have the largest market share for ostomy care market in 2017. This region is dominated in ostomy care market due to increased prevalence of inflammatory bowel diseases. In addition, increased patient awareness programs continue to drive penetration and market growth in this region.

Some of the key players in global ostomy care market include Coloplast, ConvaTec Inc., Hollister Incorporated, Alcare Co., Ltd., B. Braun Melsungen AG, BAO-Health, Welland Medical Limited, Marlen International, Nu-Hope Laboratories, Inc., and Flexicare Medical Limited among others.

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world

Contact us
Mr. Likhil
Corporate Sales, USA
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com

Organic Seed Market Increased International Trade Opening New Opportunities

New York, NY 22 Aug 2019: According to a new study published by Polaris Market Research the global organic seed market is anticipated to reach USD 5.35 billion by 2026. Growing demand for naturally derived products is the primary reason expected to drive the organic seed industry over the next seven to eight years.

For any seed to be certified as organic the producer or farmer should only use formerly grown seeds except for non-originally or non-formerly farmed untreated seeds. The planting stocks can also be used for the production of an organic crop only when an equivalent organically breeded variety is not available commercially. Organic plant breeding in several industrialized nations has increasingly employing molecular techniques. Cisgenesis and transgenesis are some of the newly introduced breeding techniques that have played significant role in increasing availability of enhanced hybrid organic seeds. SoW-1 is another new genetically modified (GM) seed breed that has been an increasing trend in the industry. The product value of GM seed that have been traded increased over 25-fold in between 1996 and 2017, from USD 280 million to around USD 7 275 million. But, only in the USA, Brazil, Argentina, India, China and South Africa have been growing significant acreages of GM crops.

Get Sample Copy of this Report @ https://www.polarismarketresearch.com/industry-analysis/organic-seed-market/request-for-sample

Various initiatives have already been promoted for both informal and formal seed systems. The African Union has been fully engaged in encouraging its member countries to take higher integrated approaches to development of hybrid seed systems including private, public and farmers’ role. In many European countries, various rules for organic seed development have been designed to further instigate local production and sales of organic seed in its or else exceedingly regulated seed industry. These regulatory advancements along with technological development in seed breeding have influenced the industry and offered new opportunities for further penetration in the seed farming business.

Europe was the largest market in 2017 and with increasing organic farming land in the region the demand of these products is further expected to increase in the near future. Organic farming or agriculture has been a boom in the region and almost every country the market is rapidly developing. The increasing production and higher penetration of these products in Europe is due to high growth rates of Poland, Spain and the Czech Republic.

Get Exclusive Discount Offer @ https://www.polarismarketresearch.com/industry-analysis/organic-seed-market/request-for-discount-pricing

Some of the leading market participants in the organic seed industry in terms of seed farming and supply include Renee’s Garden, Baker Creek Heirloom Seeds, Kusa Seed Society, Territorial Seeds Company, Arnica Kwekerij, Mass Plant, Wild Garden Seed, High Mowing Organic Seeds, Fleuren, Vitalis Organic Seeds, HILD Samen, De Bolster, Navdanya, Farm Direct Organic Seeds, Rijk Zwaan, Wild Garden Seeds, Fedco Seeds, Seed Savers Exchange, Southern Exposure Seed Exchange and Johnny’s Selected Seeds.

About Polaris Market Research

Oleochemicals Market Size to Reach USD 38.61 Billion by 2026

New York, NY 22 Aug 2019: The global oleochemicals market is expected to reach more than USD 38.61 billion by 2026 with a CAGR of 5.9% during the forecast period as per a new study released by Polaris Market Research. The report “Oleochemicals Market [By Product Type (Fatty Alcohol, Glycerin, Fatty Acid and Others); By Application (Food & Beverage, Personal Care, Detergents & Soaps, Polymers and Others); By Regions]: Market size & Forecast, 2017 – 2026”. provides an extensive analysis of present market dynamics and predicted future trends

The growth in the demand for natural derived products of food and beverage, pharmaceutical industries, chemicals are the main drivers to drive oleochemicals market.

Get Sample Copy of this Report @ https://www.polarismarketresearch.com/industry-analysis/oleochemicals-market/request-for-sample

Oleochemicals can be defined as various types of chemical products which are derivatives from vegetable triglycerides or animals, they include elements that are of petrochemical product origin. The basic oleochemicals are fatty acids, fatty alcohols, glycerin and methyl esters. Many companies are investing in research and development to innovate new formulations. Many countries are taking active part in developing new formulations that can help to cater to specific requirement from the end user industries. The companies are shifting their focus on the usage of bio-diesel. Due to the stringent rules and regulations in chemical industry, there has been rise in oil prices, this will further decrease the demand for the chemicals. There is also significant shift in the usage towards shale gas. Even though there are many challenges in the market, there is always an advantage of oleochemicals over petrochemicals. Therefore, there will be increase in demand for oleochemicals in the near future.

The consumer has shifted their focus on having healthy and nutritional food which are derived from natural origin. These is one of the main factors to increase the demand for oleochemicals market. The industry is volatile in making profit through depleting fossil fuels and this will be led for more opportunities in the usage of bio diesel. Hence, with all these advantages demand for these products are estimated to increase in the next few years.

Get Exclusive Discount Offer @ https://www.polarismarketresearch.com/industry-analysis/oleochemicals-market/request-for-discount-pricing

Asia-Pacific is one of the largest markets for oleochemicals. Increase in the production for palm kernel and palm oil is the driving factor to increase the demand for oleochemical in Asia-Pacific region. There is a rapid increase in the production of palm along with developing integration of raw materials. This has become the main reason for the reorganization in global oleochemical market. The key players in the industry are planning for many production facilities in Europe and U.S.

The key market players in the oleochemicals market are, Ecogreen Oleochemicals, SABIC, Evyap, China Sanjiang Fine Chemicals, Godrej Industries, Archer Daniels Midland, Emery Oleochemicals, Vantage Specialty Chemicals, Evonik Industries, BASF, Wilmar International, Kao Chemicals, Alnor Oil Co, Isosciences LLC, Vegetable Vitamin Foods Company, Kuala Lumpur KepongBerhad, Eastman Chemical Company, AkzoNobel, PTT Global Chemical Public Company Limited.

About Polaris Market Research

Contact us
Mr. Likhil
Corporate Sales, USA
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com

Next Generation Sequencing (NGS) Market Share, Scope, Growth Opportunities Analysis and Forecast 2026

New York, NY 22 Aug 2019: According to a new study published by Polaris Market Research, the global Next Generation Sequencing (NGS) market is anticipated to reach USD 16.6 billion by 2025. Next generation sequencing (NGS), is a DNA sequencing technology. The process of DNA sequencing, which decides the exact order of nucleotides inside a DNA molecule, is known as Next generation sequencing. Next generation sequencing is high throughput sequencing. Using next generation sequencer, the process produces a million DNA molecules and RNA sequences by allowing rapid nucleotide sequencing. Roche 454 sequencing and Illumina sequencing are the modern technologies of next generation sequencing. In comparison to Sanger’s sequencing method, the next generation sequencing is much cost-effective technique that provides better outcomes for DNA sequencing. An entire human genome can be sequenced in a single day using next generation sequencing, however, the Sanger sequencing technology, used to decode the human genome, required over a decade to bring the final summary.

By providing high flexibility, speed, throughput, and reduced sequencing cost, the introduction of next generation sequencing technologies has brought significant changes in sequencing technologies. In the single sequencing run, the next generation sequencing has ability to generate of nucleotide sequence data. The applications of next generation sequencing are in the field of cancer research, genetic disease research, personalized medicines, biological drug discovery, newborn sequencing metgenomics, and agriculture research etc. Moreover, non-coding RNA expression profiling, identification of binding sites on transcriptional factor, and re- sequencing of targets are some more applications of next generation sequencing.

Request for Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/next-generation-sequencing-ngs-market/request-for-sample

The adoption of next generation sequencing is mounting for diagnosis of inherited genetic disorders, cancer, HLA typing and identification of infectious diseases as it allows scanning of targeted genome in very small time, and this is expected to propel the growth of global next generation sequencing market over the forecast period.

The global market for next generation sequencing is segmented by application, technology, products, end user, and region. By application, the global next generation sequencing market is categorized as, drug discovery/personalized medicine, genetic screening, diagnostics/infectious diseases, agricultural & animal research, and others. The drug discovery/personalized medicine segment is estimated to account major share in global next generation sequencing market by application in 2017. The increasing demand of next generation sequencing base test for infectious diseases and cancer, and rising focus on developing and providing next generation sequencing- based diagnostic tests are the major factors contributing towards the high market share of the segment in the global market. Moreover, the growing research and development activities globally are significantly contributing towards the growth of market.

By Technology, the global next generation sequencing market is further sub segmented into Whole Genome Sequencing, Targeted Re-Sequencing, Whole Exome Sequencing, RNA Sequencing, Chip Sequencing, De Novo Sequencing, and Methyl Sequencing. By technology, the targeted sequencing & Re-sequencing segment accounted major share in global next generation sequencing market. The targeted sequencing reduces the sequencing cost, and it is target specified and also requires smaller dataset. Moreover, increasing demand target specific genomic studies s expected to propel the growth of segment in the global next generation sequencing market.

Get Exclusive Discount on This Report @ https://www.polarismarketresearch.com/industry-analysis/next-generation-sequencing-ngs-market/request-for-discount-pricing

By product, the global next generation sequencing market is further categorized into instruments, reagents & consumables, and services. By consumables, the global next generation sequencing market is further segmented into sample preparation consumables, and other consumables. The sample preparation sample includes quality control consumables, library preparation, DNA fragmentation, end repair, A-tailing, and size selection etc. On the basis of services, the global next generation market is segmented into data management services, and sequencing services. The sequencing services segment includes, Targeted Re-Sequencing, RNA Sequencing Chip-Seq, Methyl-Seq, De Novo Sequencing etc. where, the data management services includes, NGS storage, management, NGS data analysis software & workbenches, and NGS data analysis services.

On the basis of end user, the global next generation sequencing market is further segmented into healthcare institutions, pharmaceutical & biotechnology companies, research and academic centers, and others. By end user, the research and academics segment accounted major share in global next generation sequencing market. High application of next generation sequencing tools in research is the one of the key factors contributing towards the high market share of the segment. The hospitals and clinics segment is expected to register high CAGR over the forecast period owing to increasing collaboration between hospitals and biotech and pharmaceutical companies to develop advanced test kits for diagnosis of diseases.

Some of the key players operating in global next generation sequencing market are Thermo Fisher Scientific Inc., Illumina, Inc., Roche Holding AG, QIAGEN N. V., BGI (Beijing Genomics Institute), Oxford Nanopore Technologies, Ltd., Pacific Biosciences of California, Inc., GATC Biotech AG, Perkin Elmer, Inc., Agilent Technologies, Inc., Macrogen, Inc. , and Eurofins Scientific among others.

About Polaris Market Research

Monoclonal Antibodies (mAbs) Market Evaluation of Recent Industry Developments For 2018-2026

New York, NY 22 Aug 2019: According to a new study published by Polaris Market Research the worldwide monoclonal antibodies market is anticipated to reach over USD 148.9 billion by 2026. In 2017, by indication, the cancer segment dominated the global market in terms of revenue; wherein fully-human monoclonal antibodies held a major share of the market. In terms of geography, North America accounted for the majority share in the global monoclonal antibodies market.

The monoclonal antibodies (mAbs) market is mainly driven by an active pipeline, wherein many monoclonal antibodies are at the different stages of drug development. In addition, increased in research and development, favorable government policies and rising prevalence of cancer and other chronic diseases supplement the market growth. The other factors that augment that market growth include the increasing the demand for personalized medicine and rising awareness among medical professional and patients about the latest medical therapies. Moreover, emerging targets such as central nervous system disorders, price correction and new delivery strategies for monoclonal antibodies provide opportunities for market growth in the near future.

Request for Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/global-monoclonal-antibodies-mabs-market/request-for-sample

Monoclonal antibodies constitute a major share of the pharmaceutical market with several monoclonal antibodies still in the pipeline. With over 30 monoclonal antibodies approved for use by regulatory authorities, many monoclonal antibodies are in the pipeline at the pre-clinical stage and various stages of clinical trials. Furthermore, availability of advanced technology for monoclonal antibodies production has egged on many other market players to develop their own pipelines. Also, in the last few years the patents of many monoclonal antibodies have expired thereby encouraging other pharmaceutical companies to undertake production of monoclonal antibodies.

There has been an increase in the research and development activities in the field of monoclonal antibodies. Several biomedical and technological advances in genetic engineering and next generation genome sequencing have fuelled the growth of the monoclonal antibody market. Also, multiple new targets have been identified during preclinical research, which has led to the development and production of newer monoclonal antibodies by using various cytotechnological methodologies. In addition to this, favorable government initiatives to enable cost-effective production of monoclonal antibodies would give impetus to the monoclonal antibodies market growth. Also, pre-defined guidelines by regulatory bodies would ensure the safe, effective and high quality manufacturing of monoclonal antibodies Recently, the European Commission approved the first biosimilar mAb Celltrion’s Truxima (biosimilar rituximab), thereby boding well for its potential approval in the U.S.

Personalized medicine is being redefined by monoclonal antibodies that are the cutting-edge form of immunotherapy. The surge in the demand for personalized medicine plays a crucial role in boosting the monoclonal antibodies market by giving an impetus to the development of personalized drug targets as every patient responds differently to different treatment regimens. Moreover, other factors such as specificity, homogeneity and relatively fewer adverse events that entail usage of personalized medicine contribute to significant market growth.

Get Exclusive Discount on This Report @ https://www.polarismarketresearch.com/industry-analysis/global-monoclonal-antibodies-mabs-market/request-for-discount-pricing

The widespread and rapidly increasing prevalence of cancer and other chronic diseases have resulted in the soaring demand of biological medicines, thereby augmenting the growth of monoclonal antibodies. Furthermore several other monoclonal antibodies used in treatment of deadly infections such as HIV/AIDS, Ebola and Zika viral disease are in various phases of clinical trials. Also, high spending power of patients in developed countries, increasing disposable incomes in developing countries and better healthcare facilities further facilitate market growth. Going forward, increasing awareness about the latest medical therapies among medical professional and patients, and increasing utilization of monoclonal antibodies in treatment regimens is anticipated to propel the market growth.

Based on indication, the global monoclonal antibodies market is segmented in to cancer, inflammation, cardiovascular diseases, transplant rejection, respiratory and infectious diseases. The cancer segment is expected to lead the market during the forecast period owing to rapidly expanding patient pool, awareness about monoclonal antibodies among physicians and patients, improving medical facilities, high spending power in developed countries and increasing disposable incomes in developing countries.

The leading companies operating in this industry include Pfizer, Inc., GlaxoSmithKline PLC, Novartis AG, Merck & Co., Inc., Eli Lily & Co., AstraZeneca, Amgen, Inc., Abbott Laboratories, Thermo Fisher Scientific, Inc., Bistro-Myers Squibb. Mylan N.V., Daiichi Sankyo Company, Ltd., Bayer AG, Hoffmann-La Roche Ltd., and Novo Nordisk A/S. The market players have adopted various strategies such as novel product development, new product release, and venture capital investments among others to establish a foothold in the market and increase their customer base.

About Polaris Market Research

Contact us
Mr. Likhil
Corporate Sales, USA
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com

Microscope Market Evaluation of Recent Industry Developments 2025

New York, NY 22 Aug 2019: According to a new study published by Polaris Market Research the worldwide microscope market is anticipated to reach USD 12,851.2 million by 2025. In 2017, the electron microscope segment dominated the global market, in terms of revenue, whereas Asia-Pacific accounted for the majority share in the global microscope market.

Several technological advancements in the fields of nanotechnology, semiconductors and life sciences have augmented the growth of the microscope industry. In addition, this has encouraged government bodies to invest in research and development; which in turn has led to an increase in research and development activities in companies, small laboratories and academic institutions. Companies and academic institutions are increasing collaborations for shared use of advanced laboratory equipment has further supplemented market growth. The other factors driving the market growth include lightweight and portability of certain microscopes production of robust, more accurate and relatively cheaper instruments, and widespread adoption of microscope use by manufacturers across various domains. Emerging market in developing countries and newer innovative fields of application provide numerous opportunities for growth.

Request for Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/microscope-market/request-for-sample

The major driver of the growth of the microscope market is the advancements in the field of nanotechnology. Various factors such as optimal energy consumption and its conservation, environmental preservation, and increasing industrial productivity and quality by optimizing operational efficacy have fuelled the growth of nanotechnology. Also, miniaturization in semiconductor and electronics industry and material science has boosted market growth. Furthermore, the extensive use of microscopes and technological advancements in the field of forensic sciences, pharmacology, cell biology, biophysics and microbiology among other life sciences has augmented market growth.

In view of increasing technological advancements and its benefits, there has been an increase in the research and development activities in companies, small laboratories and academic institutions. It has also encouraged the government bodies to increase funding of such research and development activities. Moreover, companies and academic institutions are collaborating in order to use advanced laboratory equipment, which in turn has also supplemented market growth.

The recent technological advancements in the manufacturing process of microscopes has led to the production of robust, more accurate and relatively cheaper instruments. In addition, certain microscopes are lightweight and portability in nature which has further contributed to the market growth. Furthermore, recent advancements in commercial applications of nanotechnology, life science and semiconductor manufacturing has led to a widespread adoption of microscope use by manufacturers across various domains.

Asia-Pacific dominates the global market and is predicted to exhibit growth at the highest CAGR during the forecast period. This rapid growth is due to the swelling economic growth in countries such as China and Japan. Various factors governing the growth in this region include presence of major market players in this region, increasing government and rapidly increasing research and development activities. Furthermore, various technological advancements in the field of material and life sciences, and nanotechnology is further boosting the market growth.

Get Exclusive Discount on This Report @ https://www.polarismarketresearch.com/industry-analysis/microscope-market/request-for-discount-pricing

The different types of microscopes include optical microscopes which is further categorized into inverted microscopes, stereomicroscopes, phase contrast microscopes, fluorescence microscopes, confocal scanning microscopes, near field scanning microscopes, other optical microscopes; electron microscope which is further categorized into transmission electron microscope which is further categorized into scanning electron microscope; scanning probe microscope; and others. The electron microscope segment is expected to dominate the market during the forecast period owing to technological advancements, in the fields of material and life sciences. Electron microscope segment is further sectioned into scanning electron microscope and transmission electron microscope.

The key market players profiled in the report include Nikon, Carl Zeiss AG, Leica Microsystems, Hitachi High Technologies, Bruker Corporation, NT-MDT Company, FEI Company, Jeol Ltd., Olympus Corporation, Asylum Research, Omax Corporation, Amscope, Celestron, Motic and Magnus Analytics. These market players have adopted various strategies such as such as new product release, novel technology development and collaboration among others to expand their foothold and increase their customer base.

About Polaris Market Research

Contact us
Mr. Likhil
Corporate Sales, USA
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com

Friday, 14 June 2019

Genomics in Cancer Care Market Size to Reach $14.6 Billion by 2025 | Polaris Market Research

New York, NY 14 June 2019: The report ‘Genomics in Cancer Care Market Share, Size, Trends, & Industry Analysis Report, By Product type (Consumables, Instruments, Services); By Technology, By Application; By End Use; and By Region: Segment Forecast, 2019–2025’ provides insights on the current market scenario and the future prospects. The global genomics in cancer care market size is anticipated to reach USD 14.6 billion by 2025 growing at a CAGR of 17.7% from 2019 to 2025

In 2018, by product type, instrument segment captures the largest market shares in terms of revenue and hold major share in the market. Regionally, North America accounted for the major share in the global market.

Request for sample of this research report @ https://www.polarismarketresearch.com/industry-analysis/genomics-in-cancer-care-market/request-for-sample

The market is primarily driven by increasing prevalence of cancer patients globally, and rising demand for diagnostic coupled with the availability of cost effective and technologically advanced technology. Additionally, awareness and growing preference for personalized medicines is also influencing the market growth. Moreover, continuous investment on research and developments by the biotechnology & pharmaceutical companies would also fuel the market growth.

Product segment is further sub-segmented into consumables and reagents, instruments, and services. Instruments market holds the major share in the market owning to the rapid technological advancements, and continuous efforts by the manufacturers for providing digitalization in the instruments for its easy use. While consumables and reagents hold second largest position for market followed by the service sub segment.

Browse summary of this report with TOC @ https://www.polarismarketresearch.com/industry-analysis/genomics-in-cancer-care-market

Based on technology, the market is segmented as genome sequencing, PCR, microarray nucleic acid extraction and purification. Genome sequencing holds the major market share in 2017, and would continue to experience growth during the forecast period. The growth in this segment is majorly driven by the effective and precise diagnosis results, and rising awareness for its use in cancer diagnosis. Moreover, advantages like growing demand for cost-effective technologies, and flexibility in this technique would also influence the growth of genome sequencing market.

Onthe basis of application, the market is further segmented as diagnostics, personalized medicines, drug discovery, and Research. This application is majorly used for diagnosis of cancer. Diagnostics holds the largest market share which is majorly attributed to the growing number of cancer patients worldwide.

Research institute is the largest segment as an end user for the market, and would hold dominating position during the forecast period. The growth of genomics market in cancer care is primarily driven by the need for accurate screening techniques that gives to the point diagnosis of cancer.

Speak to Analyst to know more @ https://www.polarismarketresearch.com/industry-analysis/genomics-in-cancer-care-market/speak-to-analyst

Geographically, North America holds a dominating position in the global genomics in cancer care market followed by Europe and Asia Pacific. The market growth in North America is driven by the presence of refined research & development infrastructure for the researchers, large pool of patients suffering from cancer, and high healthcare expenditure by the individuals. Whereas, Asia Pacific is expected to reach remarkable growth owning to the increased penetration rate of these technologies and improving research and development expenditure by the biopharma industries.

The leading companies operating in this industry include Agilent Technologies, Roche Diagnostics, Beckman Coulter, Illumina, Inc., Affymetrix, Cancer Genetic Inc., Bio-Rad Labs, Pacific Bio-science, Sigma Aldrich Corporation, GE Healthcare, Quest Diagnostics, Abbott Laboratories, PerkinElmer, and Luminex.

Key Findings from the study suggest technology available in the market are continuously concentrating on the technological advancements that will reduce the efforts and provide with accurate diagnosis of cancer.

The leading companies while developing new technologies considers the factors such as increasing awareness for the use of this technology, and reaching the untapped market. North America is presumed to dominate the global market over the forecast years and Asia Pacific region shows signs of high growth owing to the booming economies of India, and China.

Get Exclusive Discount on This Report @ https://www.polarismarketresearch.com/industry-analysis/genomics-in-cancer-care-market/request-for-discount-pricing

Polaris Market Research has segmented the genomics in cancer care market on the basis of product type, technology, application, end user and region:

Genomics in Cancer Care Product Type

Consumables
Instruments
Service

Genomics in Cancer Care Technology Type

Gene Sequencing
PCR
Microarray Nucleic Acid Extraction and Purification

Genomics in Cancer Care Application

Diagnostics
Personalized Medicines
Drug Delivery
Research

Genomics in Cancer Care Product End Use

Hospitals
Research Institutes
Academic Research

About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world

Contact us
Mr. Rohit
Corporate Sales, USA
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com

Thursday, 13 June 2019

Bio-based Polymers Market Growth Opportunities, Industry Analysis, Geographic Segmentation and Competitive Landscape Report to 2026

New York, NY 13 June 2019: The global bio-based polymers market was estimated to be worth of USD 14.2 billion in 2018 and is projected to grow at a CAGR of 10% over the forecast period. The report ‘Bio-based Polymers Market Share, Size, Trends, & Industry Analysis Report, [By Product (PET, PA, PEF, PE, PUR, PBS, PHA, PTT, PBS, Epoxies, PEF, Others), By End-Use (Textile, Automotive, Films & Coatings, Electronics, Industrial), By Regions]: Segment Forecast, 2018 – 2026’ provides insights on the current market scenario and the future prospects.

Bio-based polymers are obtained through the polymerization of bio-based raw materials through engineered industrial processes. The raw materials of bio-based polymers are either isolated from plants and animals or synthesized from biomass using enzymes or microorganisms. The raw materials used for manufacturing bio-based polymers includes corn fiber, wheat by-products, food processing waste, paper mill sludge, stems, leaves, livestock waste, and others.

Request for a sample of this research report @ https://www.polarismarketresearch.com/industry-analysis/bio-based-polymers-market/request-for-sample

Initially bio-based functional polymers were derived from agricultural feedstock, but a recent breakthrough in technology has shifted focus to derive from nucleic acids, proteins, polysaccharides, and bacterial fermentation by synthesizing monomers like fatty acids, cellulose, and starch.

Increasing dependence on synthetic polymers has led to a rise in environment risks associated with disposal and recycling. The combustion of these synthetic polymers releases harmful greenhouse gasses (GHGs) and other toxic gasses into the atmosphere, thereby degrading the environment and leading to ozone depletion & global warming. Stringent environmental regulations on fossil fuel products by regulatory authorities such as the EPA and REACH coupled with government initiatives to reduce dependency on petrochemicals have been responsible for the development of bio-based alternatives.

This is further supported by the increasing awareness towards sustainability and growing demand for bio-based polymers from various end-use industries such as automotive, electrical & electronics, construction, and footwear. Bio-based construction polymer market is in its nascent phase and is estimated to witness significant growth over the next six years on account of the increasing demand from end-use industries.

Browse for full research summary: https://www.polarismarketresearch.com/industry-analysis/bio-based-polymers-market

The commercially available bio-based polymer comprises 100% biomass content. Currently, bio-based polymer is derived from corn fiber, wheat by-products, food processing waste, paper mill sludge, stems, leaves, livestock waste. However, companies have been making significant investments in developing 100% bio-based polymers, which do not require fossil fuel or petrochemical byproducts.

The bio-based polymers are manufactured through the polymerization of bio-based raw materials through engineered industrial processes. Bio-based polymers are usually manufactured from vegetable oils derived from castor, soybean, rapeseed, or sunflower corn fiber, wheat by-products, food processing waste, paper mill sludge, stems, leaves, livestock waste, and others.

The major global raw material manufacturers include companies such as Victrexplc, Mitsubishi, and Wageningen UR among several others. The bio-based content in polymer varies depending on the type of feedstock that is used during manufacturing.

Major bio-based polymer manufacturers include Cargill, Lubrizol, BASF SE, Bayer Material Science, and Dow Chemical where these companies further process polymer using numerous industrial techniques. In certain cases, some companies supply the unfinished biopolymer to other small and medium-scaled companies. Moreover, several major players operating in the market such as BASF SE, Cargill, Bayer Material Science, Bio Based Technologies, and BioAmber have forward integrated their operations, starting from producing raw materials to production of bio-based polymer.

Make Inquiry about this report @ https://www.polarismarketresearch.com/industry-analysis/bio-based-polymers-market/inquire-before-buying

Major polymer manufacturers are shifting their focus towards developing sustainable technologies and are collaborating with various individual bio-based technology manufacturers in order to produce bio-based polymers. The bio-based polymer industry is consolidated in nature and has witnessed numerous M&A over the past few years.

Polaris Market Research has segmented the global bio-based polymers market on the basis of Product, End-use and Region:

Bio-based Polymers by Product Outlook (Volume, Kilo Tons; Revenue, USD Million, 2015 – 2026)

PET

PEF

PUR

PBS

PHA

PTT

PBS

Epoxies

PEF

Others

Bio-based Polymers by End-Use Outlook (Volume, Kilo Tons; Revenue, USD Million, 2015 – 2026)

Textile

Automotive

Films & Coatings

Electronics

Industrial

Others

Bio-based Polymers by Region (Volume, Kilo Tons; Revenue, USD Million, 2015 – 2026)

North America

U.S.

Canada

Europe

Germany

France

Belgium

Asia-Pacific

China

India

Japan

Latin America

Brazil

Mexico

Argentina

Middle East and Africa

Saudi Arabia

UAE

Nigeria

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. We provide unmatched quality of offerings to our clients present globally. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base in a wide range of industries including healthcare, technology, semi-conductors and chemicals. We strive to provide our clients with updated information on innovative technologies, high growth markets, emerging business environments and the latest business-centric applications, thereby helping them to make informed decisions and leverage new opportunities.

Contact us

Mr. Rohit

Corporate Sales, USA

Polaris Market Research

Phone: 1-646-568-9980

Email: sales@polarismarketresearch.com

Web: www.polarismarketresearch.com

Colorants Market Size To Reach $79.8 Billion by 2026 | CAGR: 5.3%

New York, NY 13 June 2019: The global colorants market size estimated to be worth of USD 52.74 billion by 2026 and is projected to grow at a CAGR of 5.3% over the forecast period.

Colorants are products that have the ability of value addition and are used in various applications such as paper, food & beverages, textiles, plastics, paints, cosmetics, leather, inks, photos, and medical applications among others. They are used to transform products into aesthetically superior ones, thus benefitting the product’s demand. The global growth in key end use industries such as textiles and plastics among others, is expected to benefit the global colorants market over the forecast period.

Request for a sample of this research report @ https://www.polarismarketresearch.com/industry-analysis/colorants-market/request-for-sample

Colorants can be classified into two broad types, these include dyes and pigments. Pigments can be defined as powdered or granular substances that are insoluble and impart color by reflecting certain rays of light. Industries such as ink, paints are the major end uses of pigment paints.

Dyes are soluble substances that are employed to pass color to the substrates. Mainly, the major end — users of dyes include leather and the textile industries. Due to rising population and increasing disposable income, the textile industry has witnessed a rapid growth in the past few years. This has benefitted the dyes demand in the recent past.

The market is characterized by a shifting interest towards naturally derived colorants. There is uncertainty prevalent in the consumers regarding the safety of synthetic colors. The image of natural colorants that is perceived by consumers is good and healthy.

Browse for full research summary: https://www.polarismarketresearch.com/industry-analysis/colorants-market

Synthetic colors are being perceived as those responsible for allergenic reactions and other disorders. This has paved way for opening up of new avenues and market opportunities for natural food color manufacturers. Such trends are expected to benefit the colorants market demand over the forecast period.

Therefore, due to rising demand for natural food colors across the globe, manufacturers are evaluating novel routes to produce these colors. Biotechnological processes such as fermentation, algae cultures as well as plant cell routes are being evaluated.

The compulsory tests that have to be carried out, prior commercialization of the product, is expected to hinder market growth. Toxicology test is one of such tests. The huge investment required for Research and Development as well as for testing of the product is a huge impediment for market participants. In addition, the dislike of customers for novel products is also expected to restrain market growth. One of the other factors restraining market growth is the prevalence of stringent regulations governing the launch of new products.

Make Inquiry about this report @ https://www.polarismarketresearch.com/industry-analysis/colorants-market/inquire-before-buying

The main focus of these manufacturers is to develop a biotechnological route that can produce colors ranging from yellow to blue among others. To achieve this, researchers are focusing on the development of organisms that can produce phycobiliproteins, carotenoids and other types that possess the aforementioned colors.

Major industry participants include BASF SE, Clariant, E. I. Du Pont De Nemours and Company, Huntsman Corporation, DIC Corporation, Cabot Corporation, Dystar, Lanxess, Polyone Corporation, Sun Chemical Corporation, Ampacet Corporation, Chromatech Incorporated, Sudarshan Chemical Industries Limited, Chromatech Incorporated, Heubach Color, Holland Colours, Greenville Colorants, LLC, Solvay among others.

Polaris Market Research has segmented the global colorants market on the basis of Product, End-use and Region:

Colorants Product Outlook (Volume, Tons; Revenue, USD Million, 2015–2026)

Pigments

Organic

Inorganic

Dyes

Natural Dyes

Synthetic Dyes

Color Concentrates

Solid concentrates

Liquid concentrates

Masterbatches

Colorants End-use Outlook (Volume, Tons; Revenue, USD Million, 2015–2026)

Paper & Printing

Packaging

Building & Construction

Textiles

Automotive

Others

Colorants Region (Volume, Tons; Revenue, USD Million, 2015–2026)

North America

U.S.

Canada

Europe

Germany

France

Belgium

Italy

Spain

Asia Pacific

China

India

Japan

South Korea

Australia

Latin America

Brazil

Mexico

Middle East & Africa

Saudi Arabia

UAE

About Polaris Market Research

Contact us

Mr. Rohit

Corporate Sales, USA

Polaris Market Research

Phone: 1–646–568–9980

Email: sales@polarismarketresearch.com

Web: www.polarismarketresearch.com